Novel insights into gastric cancer: Methylation of R-spondins and regulation of LGR5 by SP1

Molecular Cancer Research

Volumn 15, Issue 6, 2017, Pages 776-785

  Wilhelm, Franziska ^a   Simon, Eva ^a   Böger, Christine ^a   Behrens, Hans Michael ^a   Krüger, Sandra ^a   Röcken, Christoph ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LEUCINE RICH REPEAT CONTAINING RECEPTOR 5; PROTEIN; PROTEIN RSPO1; PROTEIN RSPO2; RECEPTOR; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG; G PROTEIN COUPLED RECEPTOR; LGR5 PROTEIN, HUMAN; R-SPONDIN2 PROTEIN, HUMAN; RSPO1 PROTEIN, HUMAN; SIGNAL PEPTIDE; SP1 PROTEIN, HUMAN; THROMBOSPONDIN; TUMOR MARKER;

AGED; ARTICLE; CANCER PATIENT; CARCINOGENESIS; CHROMATIN IMMUNOPRECIPITATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METHYLATION; REGULATORY MECHANISM; STOMACH CANCER; STOMACH MUCOSA; DNA METHYLATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; STOMACH TUMOR; TUMOR CELL LINE;

BIOMARKERS, TUMOR; CELL LINE, TUMOR; DNA METHYLATION; GASTRIC MUCOSA; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; PROMOTER REGIONS, GENETIC; RECEPTORS, G-PROTEIN-COUPLED; SP1 TRANSCRIPTION FACTOR; STOMACH NEOPLASMS; THROMBOSPONDINS;

EID: 85020454330     PISSN: 15417786     EISSN: 15573125     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-16-0472     Document Type: Article

References (47)

1. Colquhoun A, Arnold M, Ferlay J, Goodman KJ, Forman D, Soerjomataram I. Global patterns of cardia and non-cardia gastric cancer incidence in 2012. Gut 2015;64:1881-8.
2. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136:E359-86.
3. Röcken C. [Ways to personalized medicine for gastric cancer]. Pathologe 2013;34:403-12.
4. Stojnev S, Krstic M, Ristic-Petrovic A, Stefanovic V, Hattori T. Gastric cancer stem cells: therapeutic targets. Gastric Cancer 2014;17:13-25.
5. Tetteh PW, Farin HF, Clevers H. Plasticity within stem cell hierarchies in mammalian epithelia. Trends Cell Biol 2015;25:100-8.
6. Qiao XT, Gumucio DL. Current molecular markers for gastric progenitor cells and gastric cancer stem cells. J Gastroenterol 2011;46:855-65.
7. Barker N. Adult intestinal stem cells: critical drivers of epithelial homeostasis and regeneration. Nat Rev Mol Cell Biol 2014;15:19-33.
8. Carmon KS, Gong X, Lin Q, Thomas A, Liu Q. R-spondins function as ligands of the orphan receptors LGR4 and LGR5 to regulate Wnt/betacatenin signaling. Proc Natl Acad Sci USA 2011;108:11452-7.
9. de Lau W, Barker N, Low TY, Koo BK, Li VS, Teunissen H, et al. Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling. Nature 2011;476:293-7.
10. Barker N, Huch M, Kujala P, van de Wetering M, Snippert HJ, van Es JH, et al. Lgr5(+ve) stem cells drive self-renewal in the stomach and build longlived gastric units in vitro. Cell Stem Cell 2010;6:25-36.
11. Barker N, van Es JH, Kuipers J, Kujala P, van den BornM, Cozijnsen M, et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 2007;449:1003-7.
12. Jaks V, Barker N, Kasper M, van Es JH, Snippert HJ, Clevers H, et al. Lgr5 marks cycling, yet long-lived, hair follicle stem cells. Nat Genet 2008; 40:1291-9.
13. Ng A, Tan S, Singh G, Rizk P, Swathi Y, Tan TZ, et al. Lgr5 marks stem/ progenitor cells in ovary and tubal epithelia. NatCell Biol 2014;16:745-57.
14. Kazanskaya O, Glinka A, del Barco Barrantes I, Stannek P, Niehrs C, Wu W. R-Spondin2 is a secreted activator of Wnt/beta-catenin signaling and is required for Xenopus myogenesis. Dev Cell 2004;7:525-34.
15. de Lau WB, Snel B, Clevers HC. The R-spondin protein family. Genome Biol 2012;13:242.
16. de Lau W, Peng WC, Gros P, Clevers H. The R-spondin/Lgr5/Rnf43 module: regulator of Wnt signal strength. Genes Dev 2014;28:305-16.
17. Malinauskas T, Jones EY. Extracellular modulators of Wnt signalling. Curr Opin Struct Biol 2014;29:77-84.
18. Tan S, Barker N. Epithelial stem cells and intestinal cancer. Semin Cancer Biol 2015;32:40-53.
19. Clevers H. An integral program for tissue renewal and regeneration: Wnt signaling and stem cell control. Science 2014;346:1248012.
20. Ong BA, Vega KJ, Houchen CW. Intestinal stem cells and the colorectal cancer microenvironment. World J Gastroenterol 2014;20: 1898-909.
21. Chiurillo MA. Role of the Wnt/b-catenin pathway in gastric cancer: An in-depth literature review. World J Exp Med 2015;5:84-102.
22. Xi HQ, Cai AZ, Wu XS, Cui JX, ShenWS, Bian SB, et al. Leucine-rich repeatcontaining G-protein-coupled receptor 5 is associated with invasion, metastasis, and could be a potential therapeutic target in human gastric cancer. Br J Cancer 2014;110:2011-20.
23. Li XB, Yang G, Zhu L, Tang YL, Zhang C, Ju Z, et al. Gastric Lgr5 stem cells are the cellular origin of invasive intestinal-type gastric cancer in mice. Cell Res 2016;26:838-49.
24. Simon E, Petke D, Boger C, Behrens HM, Warneke V, Ebert M, et al. The spatial distribution of LGR5+ cells correlates with gastric cancer progression. PLoS One 2012;7:e35486.
25. The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature 2014;513:202-9.
26. Cristescu R, Lee J, Nebozhyn M, Kim KM, Ting JC, Wong SS, et al. Molecular analysis of gastric cancer identifies subtypes associatedwith distinct clinical outcomes. Nat Med 2015;21:449-56.
27. Li S, Zhu X, Liu B, Wang G, Ao P. Endogenous molecular network reveals two mechanisms of heterogeneity within gastric cancer. Oncotarget 2015;6:13607-27.
28. Fenoglio-Preiser C, Carneiro F, Correa P, Guilford P, Lambert R. Gastric carcinoma. In: Hamilton SR, Aaltonen LA, eds. Pathology and genetics of tumours of the digestive system. WHO classification of tumours. Lyon, France: IARC; 2000.
29. Sobin LH, Compton CC. TNM seventh edition: what's new, what's changed: communication from the International Union Against Cancer and the American Joint Committee on Cancer. Cancer 2010;116:5336-9.
30. McCarty KS Jr, Miller LS, Cox EB, Konrath J, McCarty KSSr. Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch Pathol Lab Med 1985;109:716-21.
31. Li LC, Dahiya R. MethPrimer: designing primers for methylation PCRs. Bioinformatics 2002;18:1427-31.
32. Wu C, Qiu S, Lu L, Zou J, Li WF, Wang O, et al. RSPO2-LGR5 signaling has tumour-suppressive activity in colorectal cancer. Nat Commun 2014;5: 3149.
33. Benjamini Y. Discovering the false discovery rate. J Royal Stat Soc 2010; 72:405-16.
34. Wilhelm F, Böger C, Krüger S, Behrens HM, Röcken C. Troy is expressed in human stomach mucosa and a novel putative prognostic marker of intestinal type gastric cancer. Oncotarget 2016 Jul 8. doi: 10.18632/oncotarget.10672. [Epub ahead of print].
35. Koo BK, Clevers H. Stem cells marked by the R-spondin receptor LGR5. Gastroenterology 2014;147:289-302.
36. Sato T, van Es JH, Snippert HJ, Stange DE, Vries RG, van den Born M, et al. Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts. Nature 2011;469:415-8.
37. Ziskin JL, Dunlap D, Yaylaoglu M, Fodor IK, Forrest WF, Patel R, et al. In situ validation of an intestinal stem cell signature in colorectal cancer. Gut 2013;62:1012-23.
38. Jang BG, Lee BL, Kim WH. Distribution of LGR5+ cells and associated implications during the early stage of gastric tumorigenesis. PLoS One 2013;8:e82390.
39. Wang T, Yeoh KG, Salto-Tellez M. Lgr5 expression is absent in human premalignant lesions of the stomach. Gut 2012;61:1777-8.
40. Tsuji S, Kawasaki Y, Furukawa S, Taniue K, Hayashi T, Okuno M, et al. The miR-363-GATA6-Lgr5 pathway is critical for colorectal tumourigenesis. Nat Commun 2014;5:3150.
41. Schuijers J, Junker Jan P, MokryM, Hatzis P, Koo B-K, Sasselli V, et al. Ascl2 acts as an R-spondin/Wnt-responsive switch to control stemness in intestinal crypts. Cell Stem Cell 2015;16:158-70.
42. Li L, Davie JR. The role of Sp1 and Sp3 in normal and cancer cell biology. Ann Anat 2010;192:275-83.
43. Wang L, Wei D, Huang S, Peng Z, Le X, Wu TT, et al. Transcription factor Sp1 expression is a significant predictor of survival in human gastric cancer. Clin Cancer Res 2003;9:6371-80.
44. Yang WJ, Song MJ, Park EY, Lee JJ, Park JH, Park K, et al. Transcription factors Sp1 and Sp3 regulate expression of human ABCG2 gene and chemoresistance phenotype. Mol Cells 2013;36:368-75.
45. Szalad A, Katakowski M, Zheng X, Jiang F, Chopp M. Transcription factor Sp1 induces ADAM17 and contributes to tumor cell invasiveness under hypoxia. J Exp Clin Cancer Res 2009;28:129.
46. Kim KA, Kakitani M, Zhao J, Oshima T, Tang T, Binnerts M, et al. Mitogenic influence of human R-spondin1 on the intestinal epithelium. Science 2005;309:1256-9.
47. Ying Y, Tao Q. Epigenetic disruption of the WNT/beta-catenin signaling pathway in human cancers. Epigenetics 2009;4:307-12.